ISU ABXIS Co. Ltd is a Korea-based company engaged in pharmaceutical business. The Company operates its business under two divisions: medicine business division and diagnostic business division. Its medicine business division develops Cloticab, which is a monoclonal therapeutic antibody for thrombus. Its diagnostic business division provides genetic testing services and chemotherapy response assay services, for cancer examination. The Company is a part of ISU CORPORATION.